Back to Journals » Drug Design, Development and Therapy » Volume 9

Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses

Total article views   HTML views PDF downloads Totals
17,950 Dovepress* 17,335+ 1,075 18,410
PubMed Central* 615 199 814
Totals 17,950 1,274 19,224
*Since 13 November 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar